Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05962034 · ClinicalTrials.gov registry record · Phase 4
Thromboxane Function in Women With Endometriosis
A Phase 4 study of Endometriosis, sponsored by Penn State University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 96
- Enrollment target
- 1
- Study location
NCT05962034 is a Phase 4 study of Endometriosis that is actively recruiting participants, run by Penn State University. The registered enrollment target is 96 participants, below the 262-participant average among 48 other Endometriosis trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05962034, a Phase 4 study of Endometriosis, is actively recruiting participants, sponsored by Penn State University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 96 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare neurovascular regulation in women with endometriosis and healthy women. The main questions it aims to answer are: * Do women with endometriosis have greater blood pressure and pain responses to a stimulus than healthy women? * Do women with endometriosis have greater platelet activity than healthy women? Participants will take aspirin and/or placebo and will: * perform hand grip exercise and cold pressor tests * undergo iontophoresis and blood draw Researchers will compare women with and without endometriosis to see if there is a difference in neurovascular regulation.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Aspirin
Study Locations (1)
Pennsylvania
- Noll Laboratory - University Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2027-08-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05962034
The ClinicalTrials.gov registry entry for NCT05962034 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 262-participant average among 48 other Endometriosis trials with a reported enrollment target (63% lower). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Endometriosis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05962034 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05962034 about?
NCT05962034 is a clinical study titled "Thromboxane Function in Women With Endometriosis". The goal of this clinical trial is to compare neurovascular regulation in women with endometriosis and healthy women. The main questions it aims to answer are: * Do women with endometriosis have greater blood pressure and pain responses to a stimulus than healthy women? * Do women with endometriosi...
What is the current status of trial NCT05962034?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 96 participants. The study started on 2024-01-01. Estimated completion is 2027-08-01.
What conditions does trial NCT05962034 study?
This clinical trial studies the following conditions: Endometriosis.
What interventions are being tested in trial NCT05962034?
The interventions under investigation include: Placebo (OTHER), Aspirin (DRUG).
Who is sponsoring clinical trial NCT05962034?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05962034 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometriosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Superior Hypogastric Nerve Plexus Block With Bupivacaine After Robotic Resection of Endometriosis
RECRUITING · Phase 4
-
Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee
RECRUITING · Phase 4
-
The Use of Low Dose Metronidazole to Decrease Postoperative Pain After Endometriosis Surgery
ACTIVE NOT RECRUITING · Phase 4
-
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
COMPLETED · Phase 4
-
Supplementation in Adolescent Girls With Endometriosis
COMPLETED · Phase 4
-
Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.